Author

Mark C. Behrens

University of BernORCID 0009-0008-1228-1627Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Lukas‐Adrian GurzeleriD· 1 shared Mona WidheiD· 1 shared My HedhammariD· 1 shared Paola LucianiiD· 1 shared Sarah TeworteiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Lukas‐Adrian GurzelerORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pharmacology & ToxicologySmallPeer-reviewedFeb 19, 2025

A Fibronectin (FN)-Silk 3D Cell Culture Model as a Screening Tool for Repurposed Antifibrotic Drug Candidates for Endometriosis

Sarah Teworte, Mark C. Behrens, Mona Widhe…·Paola Luciani

This paper develops a 3D cell culture model using fibronectin-silk matrices to study endometriosis fibrosis and tests pirfenidone as a repurposed antifibrotic drug candidate.

3 citations

humanbulk RNA-seq

𝕏 PostBluesky